2012
DOI: 10.1016/j.jneumeth.2011.09.005
|View full text |Cite
|
Sign up to set email alerts
|

In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
35
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
2

Relationship

4
5

Authors

Journals

citations
Cited by 55 publications
(37 citation statements)
references
References 37 publications
1
35
0
1
Order By: Relevance
“…2-NBDG is a newly developed fluorescent 2-deoxyglucose (2-DG) analog (Bem et al, 2007; Cheng et al, 2006; Gaudreault et al, 2008; Itoh et al, 2004; Langsner et al, 2011; Millon et al, 2011; O’Neil et al, 2005; Sheth et al, 2009; Tsytsarev et al, 2012). Like the FDG (molecular weight: 181) used in PET studies, 2-NBDG is transported into cells via the same GLUT as glucose (Sheth et al, 2009).…”
Section: Methodsmentioning
confidence: 99%
“…2-NBDG is a newly developed fluorescent 2-deoxyglucose (2-DG) analog (Bem et al, 2007; Cheng et al, 2006; Gaudreault et al, 2008; Itoh et al, 2004; Langsner et al, 2011; Millon et al, 2011; O’Neil et al, 2005; Sheth et al, 2009; Tsytsarev et al, 2012). Like the FDG (molecular weight: 181) used in PET studies, 2-NBDG is transported into cells via the same GLUT as glucose (Sheth et al, 2009).…”
Section: Methodsmentioning
confidence: 99%
“…Prior work has shown that 2-NBDG enters a cell via glucose transporters and is phosphorylated at the C-6 position by hexokinases I-II. The phosphorylated fluorescent metabolite, 2-NBDG-6-phosphate, remains in the cell until decomposition into a nonfluorescent form (9)(10)(11)(12)(13). Compared with nonmalignant cells, 2-NBDG is rapidly taken up by malignant cells, providing an optical marker for detection of malignant cells.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, the distribution of these glucose substitutes is a good reflection of metabolic activity [14, 15, 67]. A fluorescent glucose substitute, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG), was successfully used for visualization of neural activity in vitro as well as in vivo [64, 67]. In experimental and clinical practice, a radioactive beam limits the usage of the radioactive labeled 2-DG analog.…”
Section: Metabolic-related Optical Imagingmentioning
confidence: 99%
“…In the study, performed with participation of one of the authors [64, 67], 2-NBDG was employed for visualization of in vivo epileptic activities induced by intracortical injection of 4-aminopyridine (4-AP), which is a common potassium-channel inhibitor that causes epileptic activity. The increased uptake rate of 2-NBDG at the injection site of 4-AP reflected increased cortical metabolism caused by epileptic seizures and produced a fluorescent signal in this site.…”
Section: Metabolic-related Optical Imagingmentioning
confidence: 99%